Literature DB >> 14678753

The C289G and C418R missense mutations cause rapid sequestration of human Parkin into insoluble aggregates.

Wen-Jie Gu1, Olga Corti, Francisco Araujo, Cornelia Hampe, Sandrine Jacquier, Christoph B Lücking, Nacer Abbas, Charles Duyckaerts, Thomas Rooney, Laurent Pradier, Merle Ruberg, Alexis Brice.   

Abstract

Mutations in the parkin gene are responsible for autosomal recessive parkinsonism. The disease-linked missense mutations are highly concentrated in the RING-IBR-RING domains of Parkin. In this study, we investigated the consequences of several missense parkin gene mutations in cell culture. We have demonstrated that two of these mutations (C289G and C418R), which replace consensus cysteine residues in the RING domains, significantly decrease the solubility of Parkin in cells. Upon overexpression, the presumably misfolded proteins formed cytoplasmic aggregates that concentrated into large perinuclear inclusion bodies when proteasome activity was inhibited. This process required active microtubule-dependent retrograde transport, as previously reported for aggresome formation. These results provide information on the molecular basis of the loss of function caused by mutations of critical residues in Parkin. They also contribute to our understanding of the cellular mechanism underlying the aggregation of mutant Parkin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14678753     DOI: 10.1016/j.nbd.2003.08.011

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  28 in total

Review 1.  Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences.

Authors:  Nicole Exner; Anne Kathrin Lutz; Christian Haass; Konstanze F Winklhofer
Journal:  EMBO J       Date:  2012-06-26       Impact factor: 11.598

2.  Early-onset Parkinson's disease caused by a novel parkin mutation in a genetic isolate from north-eastern Brazil.

Authors:  Hsin F Chien; Christan F Rohé; Maria D L Costa; Guido J Breedveld; Ben A Oostra; Egberto R Barbosa; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2005-11-22       Impact factor: 2.660

Review 3.  The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases.

Authors:  Konstanze F Winklhofer; Jörg Tatzelt; Christian Haass
Journal:  EMBO J       Date:  2008-01-23       Impact factor: 11.598

4.  Structural and Functional Impact of Parkinson Disease-Associated Mutations in the E3 Ubiquitin Ligase Parkin.

Authors:  Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer
Journal:  Hum Mutat       Date:  2015-06-03       Impact factor: 4.878

5.  HSPA1A-independent suppression of PARK2 C289G protein aggregation by human small heat shock proteins.

Authors:  Melania Minoia; Corien Grit; Harm H Kampinga
Journal:  Mol Cell Biol       Date:  2014-07-14       Impact factor: 4.272

6.  Biochemical features of ceruloplasmin gene mutations linked to aceruloplasminemia.

Authors:  Satoshi Kono; Hitoshi Suzuki; Toshiaki Oda; Hiroaki Miyajima; Yoshitomo Takahashi; Kentaro Shirakawa; Kuniko Ishikawa; Masatoshi Kitagawa
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

7.  Consequences of MEGF10 deficiency on myoblast function and Notch1 interactions.

Authors:  Madhurima Saha; Satomi Mitsuhashi; Michael D Jones; Kelsey Manko; Hemakumar M Reddy; Christine C Bruels; Kyung-Ah Cho; Christina A Pacak; Isabelle Draper; Peter B Kang
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

8.  Cone opsin determines the time course of cone photoreceptor degeneration in Leber congenital amaurosis.

Authors:  Tao Zhang; Ning Zhang; Wolfgang Baehr; Yingbin Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-09       Impact factor: 11.205

9.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

Review 10.  How does parkin ligate ubiquitin to Parkinson's disease?

Authors:  Philipp J Kahle; Christian Haass
Journal:  EMBO Rep       Date:  2004-07       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.